Filing Details
- Accession Number:
- 0001209191-16-113791
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-04-08 18:14:25
- Reporting Period:
- 2016-03-17
- Filing Date:
- 2016-04-08
- Accepted Time:
- 2016-04-08 18:14:25
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1087294 | Cumberland Pharmaceuticals Inc | CPIX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1408568 | R Thomas Lawrence | 2525 West End Ave. Suite 950 Nashville TN 37203 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2016-03-17 | 5,000 | $4.34 | 45,381 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2016-04-06 | 6,000 | $4.34 | 51,381 | No | 4 | A | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | A | Direct |
Footnotes
- Shares sold to Cumberland Pharmaceuticals Inc.
- Restricted stock award will vest 100% on March 18, 2017.